Fuji Pharma Co., Ltd. (TYO:4554)
2,295.00
-39.00 (-1.67%)
Jun 19, 2026, 3:30 PM JST
Fuji Pharma Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Fuji Pharma stock has a consensus rating of "Strong Buy" and an average price target of ¥2,700. The average 1-year stock price forecast is 17.65% higher than the current stock price, while the lowest is ¥2,000 (-12.85%) and the highest is ¥3,400 (+48.15%).
Price Target: ¥2,700 (+17.65%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Fuji Pharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Nov '25 | Feb '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Financial Forecast
Revenue This Year
55.68B
from 51.68B
Increased by 7.74%
Revenue Next Year
61.06B
from 55.68B
Increased by 9.66%
EPS This Year
n/a
EPS Next Year
n/a
Financial currency is JPY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 61.5B | ||
| Avg | 55.7B | ||
| Low | 49.9B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 19.0% | ||
| Avg | 7.7% | ||
| Low | -3.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |
EPS Growth
| EPS Growth | 2027 | 2028 |
|---|---|---|
| High | - | |
| Avg | - | |
| Low | - |